Back to search

Article

Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational study

2022-05-20

Abstract excerpt

<h4>Summary</h4> <h4>Background</h4> Effectiveness of oral antivirals in mild-to-moderate COVID-19 patients is urgently needed. This retrospective cohort study aims to evaluate the clinical and virologic outcomes associated with molnupiravir and nirmatrelvir/ritonavir use in COVID-19 patients during a pandemic wave dominated by the Omicron BA.2 subvariant. <h4>Methods</h4> We analyzed data from a territory-wide re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c5f2a53c-f935-5b5a-813a-ef436d410298
DOI
10.1101/2022.05.19.22275291
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during Hong Kong’s Omicron BA.2 wave: an observational studyDOI 10.1101/2022.05.19.22275291
Select a neighboring publication to make it the new centre.